Tristel
TSTL · AIM · Health Care · mcap £199m · 432.5p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 11 Aug 26 | Exercise of Share Options and Total Voting Rights
Exercise of Share Options and Total Voting Rights |
+0.0% | |
| 31 Jul 26 | Exercise of Share Options and Total Voting Rights
Exercise of Share Options and Total Voting Rights |
−0.9% | |
| 27 Jul 26 | 3T Pro commercial launch
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces the commercial launch of 3T Pro, a premium tier within its 3T digital compliance platform. |
−8.4% | |
| 22 Jul 26 | Trading update | Positive Trading Update
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces a trading update for the year ended 30 June 2026 ("FY 2026"). |
+1.3% |
| 07 Jul 26 | APIC26 Annual Conference attendance
Strong clinical engagement and growing U.S. presence at largest annual infection prevention conference |
−2.5% | |
| 17 Jun 26 | Board change | Appointment of CEO
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces the appointment of Christopher ("Chris") Lee as Chief Executive Officer ("CEO"), with effect from 1 August 2026. |
+0.0% |
| 10 Jun 26 | Exercise of Share Options & Total Voting Rights
Exercise of Share Options and Total Voting Rights |
+0.0% | |
| 13 May 26 | Exercise of Share Options and Total Voting Rights
Exercise of Share Options and Total Voting Rights |
+0.6% | |
| 05 May 26 | Exercise of Share Options and Total Voting Rights
Exercise of Share Options and Total Voting Rights |
+1.2% | |
| 18 Mar 26 | Conference attendance at ShareSoc Leeds
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that Tristel will be presenting at the ShareSoc Growth Company investor event on 14 April 2026, which will be held at Clayton Hotel, C |
−1.3% | |
| 03 Mar 26 | PCA Dealing
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that it was notified on 3 March 2026 that Glenn Stephens, a PCA of Caroline Stephens, Non-Executive Director of the Company, purchased |
−4.3% | |
| 02 Mar 26 | Results | Half-year Results
Unaudited Interim Results for the six months ended 31 December 2025 |
−0.7% |
| 12 Feb 26 | Exercise of Share Options and Total Voting Rights
Exercise of Share Options and Total Voting Rights |
+0.2% | |
| 06 Feb 26 | Exercise of Share Options and Total Voting Rights
Exercise of Share Options and Total Voting Rights |
+1.8% | |
| 22 Jan 26 | Trading update | Positive H1 Trading Update & Directorate Change
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces a positive trading update for the six months ended 31 December 2025. |
+0.6% |
| 08 Jan 26 | Exercise of Share Options and Total Voting Rights
Exercise of Share Options and Total Voting Rights |
+1.2% | |
| 12 Dec 25 | Exercise of Share Options and Total Voting Rights
Exercise of Share Options and Total Voting Rights |
+8.1% | |
| 11 Dec 25 | AGM Statement
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, will hold its Annual General Meeting at 11am today at the offices Company's headquarters, Unit 1b Lynx Business Park, Fordham Road Snailwell, Ne |
+3.5% | |
| 24 Nov 25 | Director Option Grant
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that on 24 November 2025 it granted a total of 181,972 new share options (the "Options") over ordinary shares of 1 pence each ("Ordina |
+1.7% | |
| 24 Nov 25 | Updated US guidelines for high level disinfection
American Institute of Ultrasound in Medicine expands U.S. |
+1.7% | |
| 16 Oct 25 | Exercise of Share Options and Total Voting Rights
Exercise of Share Options and Total Voting Rights |
−1.4% | |
| 13 Oct 25 | Exercise of Share Options and Total Voting Rights
Exercise of Share Options and Total Voting Rights |
+0.6% | |
| 13 Oct 25 | Results | Final Results
Another year of double-digit revenue growth, 23% growth in adj. pre-tax profits and strong cash generation |
+0.6% |
| 09 Oct 25 | Exercise of Share Options and Total Voting Rights
Exercise of Share Options and Total Voting Rights |
−0.7% |
Company filings. Not investment advice.